Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3085 results about "Quinoline" patented technology

Quinoline is a heterocyclic aromatic organic compound with the chemical formula C₉H₇N. It is a colorless hygroscopic liquid with a strong odor. Aged samples, especially if exposed to light, become yellow and later brown. Quinoline is only slightly soluble in cold water but dissolves readily in hot water and most organic solvents. Quinoline itself has few applications, but many of its derivatives are useful in diverse applications. A prominent example is quinine, an alkaloid found in plants. 4-Hydroxy-2-alkylquinolines (HAQs) are involved in antibiotic resistance.

Thiazolidinedione compound containing quinoline structure and application of thiazolidinedione compound

The invention relates to the field of medicinal chemistry, in particular to thiazolidinedione compounds containing quinoline structures and application of the thiazolidinedione compounds. The compound can influence the interaction between KRAS and downstream protein cRaf, namely indirectly inhibits the function of KRAS, and further inhibits the proliferation of tumor cells, and the compound and the pharmaceutical preparation thereof can be used for treating a series of diseases caused by KRAS dysfunction, mainly KRASG12D related cancers, such as KRASG12D related cancers, KRASG12D related cancers, KRASG12D related cancers, KRASG12D related cancers, KRASG12D related cancers, KRASG12D related cancers, for example, colon cancer, rectal cancer, pancreatic cancer, lung cancer, endometrial cancer, skin cancer and the like.
Owner:SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI

Hydroxyl-substituted dihydroisoquinolinone compound as well as preparation method and application thereof

The invention belongs to the technical field of medicinal chemistry, and particularly relates to a hydroxyl-substituted dihydroisoquinolinone compound. The compound has a good KRAS G12V mutant gene inhibition effect, and can be used for treating tumor diseases related to KRAS G12V gene mutation.
Owner:SHANGHAI QILU PHARMACEUTICAL RESEARCH & DEVELOPMENT CENTRE LTD

Quinoline compound and application thereof

The invention relates to the field of medicinal chemistry, in particular to quinoline compounds or pharmaceutically acceptable salts, isomers, solvates, compositions and medical application thereof. Pharmacological tests prove that the quinoline compound disclosed by the invention has a relatively good affinity effect on KRASG12D-cRaf. When the concentration is 10 M, the compound C1, the compound C3, the compound C4, the compound C6, the compound C11, the compound C12, the compound C13, the compound C16, the compound C22 and the compound C23 have a certain inhibition effect on KRASG12D-cRaf. Particularly, the compound C1 and the compound C12 both show a strong inhibition effect on KRASG12D-cRaf.
Owner:SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI

Rubber composition, side rubber, and tire

PCT designated stage expiredWO2025028624A1Special tyresPolymer scienceQuinoline
The present invention addresses the problem of providing a rubber composition with which it is possible to improve the ratio of a sustainable material in a rubber product and to improve the elongation at break (EB) after heat deterioration. The rubber composition is characterized in that: it contains a rubber component (A), recovered carbon black (B), a quinoline-based anti-aging agent (C), and a zinc oxide (D); in that the total styrene content of the rubber component (A) is less than or equal to 5 mass%; and in that the mass ratio [zinc oxide (D) / quinoline-based anti-aging agent (C) ] between the zinc oxide (D) and the quinoline-based anti-aging agent (C) is greater than 0 and less than or equal to 3.0.
Owner:BRIDGESTONE CORP

Particulate composition

The disclosure relates to a particulate composition comprising ensifentrine, wherein the particulate composition further comprises: from greater than 0.00 wt % to 0.60 wt % of 1,3-bis(2-(2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido [6,1-a]isoquinolin-3(4H)-yl)ethyl)urea (BMIQU) relative to the total weight of ensifentrine; and from 0.00 wt % to 0.50 wt % of a biuret impurity of formula (A) relative to the total weight of ensifentrine. Further disclosed herein are liquid pharmaceutical compositions comprising the particulate composition, and a process for producing the particulate composition are also described.
Owner:VERONA PHARMA

Quinolinone compound, preparation method and application of quinolinone compound in prevention and treatment of plant diseases

The invention belongs to the technical field of medicinal chemistry, and particularly relates to quinolinone compounds, a preparation method and application of the quinolinone compounds in prevention and treatment of plant diseases. Compared with the prior art, the quinolinone compound is synthesized and applied to plant disease control, and the technical problem that the bacterial disease treatment effect of a chemical bactericide is reduced due to the fact that the resistance of original bacteria to the bactericide is enhanced in the plant bacterial disease treatment process is solved.
Owner:GAUNGXI TIANYUAN BIOCHEM

Crystal of quinoline-substituted compound

The present invention addresses the problem of providing a crystal of a compound having EGFR inhibition ability or a salt thereof, said crystal being excellent in the characteristic of stability (heat, purity) and / or low hygroscopicity. One aspect of the present invention provides a crystal form of (S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide that has a peak at a prescribed angle as the diffraction angle (2θ±0.2°) in a powder X-ray diffraction spectrum.
Owner:TAIHO PHARMA CO LTD

Cation-dyeable polyester fiber structure, production method of the same, and uniform for medical use

To provide a cation-dyeable polyester fiber structure, a production method of the same, and a uniform for medical use.SOLUTION: A cation-dyeable polyester fiber structure includes a cationic dye, a quinoline compound, and an ultraviolet absorber, where 0.03 mass% or more and 0.80 mass% or less of the quinoline compound is included to a mass of the cation-dyeable polyester fiber structure, a color difference ΔE between before and after irradiating the cation-dyeable polyester fiber structure with ultraviolet carbon arc lamplight is 2.0 or lower, and an antibacterial activity value A50 after 50 times of high temperature acceleration washing is larger than a standard cloth growth value F in an antibacterial evaluation method described in an SEK mark textile product certification standard.SELECTED DRAWING: None
Owner:TORAY INDUSTRIES INC

Solid form of a quinoline carboxamide compound

The present invention relates to a crystalline polymorph of the compound of formula (I) which has a powder X-ray diffraction pattern comprising at least three 2θ angle values selected from the group consisting of consisting of 7.1 ±0.2, 7.8 ± 0.2°, 8.9 ± 0.2°, 11.4 ± 0.2°, 13.5 ± 0.2°, 14.2 ± 0.2°, 14.7 ± 0.2°, 16.2 ± 0.2°, 17.7 ± 0.2°, 18.4 ± 0.2°, 20.0 ± 0.2°, 20.8 ± 0.2°, 21.2 ± 0.2°, 21.5 ± 0.2°, 22.3 ± 0.2°, 22.9 ± 0.2°, 23.6 ± 0.2°, 24.0 ± 0.2°, 24.3 ± 0.2°, 25.0 ± 0.2°, 26.2 ± 0.2°, 27.3 ± 0.2°, 27.7 10 ± 0.2°, 28.6 ± 0.2°, 29.6 ± 0.2°, 30.3 ± 0.2°.
Owner:SYNGENTA CROP PROTECITON AG

Low-temperature curing polyimide precursor solution and preparation method thereof

PendingCN119285947AFacilitate cross-linkingincreased tangleFiberPolymer science
The invention relates to a low-temperature curing polyimide precursor solution and a preparation method thereof. The method comprises the following steps: carrying out condensation polymerization reaction on a dianhydride monomer and a diamine monomer in a reaction solvent to obtain a polyamide acid solution; and adding an amino compound containing one or more special functional groups of pyridine, imidazole, quinoline, pyrimidine and azine into the polyamide acid solution, and fully stirring to enable amino in the compound to fully react with carboxyl in a polyamide acid molecular chain, thereby obtaining the polyimide precursor solution capable of being cured at low temperature. According to the preparation method, the curing temperature of polyimide can be greatly reduced, meanwhile, the mechanical property of the material can be improved, the thermal expansion coefficient can be reduced, and the preparation method can be used for preparing polyimide binders, photoresist, electronic packaging, resin, films, fibers and aerogel.
Owner:HANGZHOU INST OF ADVANCED MATERIAL BEIJING UNIV OF CHEM TECH

Particulate composition

The disclosure relates to a particulate composition comprising ensifentrine, wherein the particulate composition further comprises: from greater than 0.00 wt % to 0.60 wt % of 1,3-bis(2-(2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl)ethyl)urea (BMIQU) relative to the total weight of ensifentrine; and from 0.00 wt % to 0.50 wt % of a biuret impurity of formula (A) relative to the total weight of ensifentrine. Further disclosed herein are liquid pharmaceutical compositions comprising the particulate composition, and a process for producing the particulate composition are also described.
Owner:VERONA PHARMA

Particulate composition

The disclosure relates to a particulate composition comprising ensifentrine, wherein the particulate composition further comprises: from greater than 0.00 wt % to 0.60 wt % of 1,3-bis(2-(2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl)ethyl)urea (BMIQU) relative to the total weight of ensifentrine; and from 0.00 wt % to 0.50 wt % of a biuret impurity of formula (A) relative to the total weight of ensifentrine. Further disclosed herein are liquid pharmaceutical compositions comprising the particulate composition, and a process for producing the particulate composition are also described.
Owner:VERONA PHARMA

1,3-dihydro-2h-pyrrolo[3,4-c]quinoline derivatives as CGAS inhibitors for the treatment of inflammatory and / or autoimmune diseases

The present invention relates to novel compounds, to said compounds for use as a medicine, more in particular for the prevention or treatment of diseases mediated by activity of cGAS, yet more in particular for the prevention or treatment of inflammation conditions or cancer. The present invention also relates to a method for the prevention or treatment of said diseases comprising the use of the novel compounds. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds as well as to said compositions or preparations for use as a medicine, more preferably for the prevention or treatment of diseases mediated by activity of cGAS, yet more in particular for the prevention or treatment of inflammation conditions or cancer. The present invention also relates to processes for the preparation of said compounds.
Owner:KATHOLIEKE UNIV LEUVEN +1

Particulate composition comprising ensifetrine

PCT designated stage expiredWO2025003643A1Organic active ingredientsPowder deliveryIsoquinolineMedicine
The invention relates to a particulate composition comprising ensifentrine, wherein the particulate composition further comprises: from greater than 0.00 wt% to 0.60 wt% of 1,3-bis(2-(2-(mesitylimino)-9, 10-dimethoxy-4-oxo-6,7-dihydro-2H- pyrimido[6,1-a]isoquinolin-3(4H)-yl)ethyl)urea (BMIQU) relative to the total weight of ensifentrine; and from 0.00 wt% to 0.50 wt% of a biuret impurity of formula (A) relative to the total weight of ensifentrine. A liquid pharmaceutical composition comprising the particulate composition, and a process for producing the particulate composition are also described.
Owner:VERONA PHARMA

Small tower footing alkali polishing additive suitable for high back contact of TOPCon battery and use method of small tower footing alkali polishing additive

The invention discloses a small tower footing alkali polishing additive suitable for high back contact of a TOPCon battery and a use method of the small tower footing alkali polishing additive, and relates to the technical field of monocrystalline silicon polishing. Comprising the following components: a corrosion catalyst, a multi-carboxyl polymer, a high-wetting defoaming agent, a surfactant, a chelating agent, a protective agent, hyperbranched polylysine, tannic acid, quinoline yellow, caffeine, 3-(N-morpholinyl)-2-sodium hydroxypropanesulfonate and deionized water. The alkali polishing additive is good in polishing effect under the condition of low weight loss, a relatively rough small-size tower footing can be formed on the back face of a silicon wafer after alkali polishing, and the cell conversion efficiency is gained.
Owner:JIAXING XIAOCHEN PHOTOVOLTAIC TECH CO LTD

Complex water quality flow-back fluid directly-prepared functional fracturing fluid

The invention discloses a functional fracturing fluid directly prepared from flow-back fluid of complex water quality. The fracturing fluid is prepared by directly adding a salt-tolerant polymer and an ion trapping agent into the flow-back fluid. The addition amount of the salt-tolerant polymer accounts for 0.15-0.3% of the total mass of the fracturing fluid, and the addition amount of the ion trapping agent is 100-500ppm. The salt-tolerant polymer is prepared by copolymerization of acrylamide, a salt-tolerant monomer and an allyl quinoline monomer, and the molecular weight of the polymer is 4-15 million. The salt-tolerant monomer is acrylamide polyoxyethylene sodium benzenesulfonate or acrylamide sodium sulfonate. The ion trapping agent is prepared from amino trimethylene phosphonic acid, diethylene triamine penta (methylene phosphonic acid), ethylene glycol bis (2-aminoethyl ether) tetraacetic acid, p-methylphenyl diethanol amine, 2, 3-epoxypropyl trimethyl ammonium chloride, fatty alcohol-polyoxyethylene ether, citric acid and tetrahydrofurfuryl acrylate. The fracturing fluid can be directly prepared from the flow-back fluid, the flow-back fluid does not need to be pretreated, and repeated utilization of the fracturing flow-back fluid is achieved.
Owner:CHENGDU LEARN PRACTICES TECH CO LTD

Tetrahydrobenzo-quinoline sulfonamides derivative compounds

ActiveUS12410161B2Organic chemistryRespiratory disorderDiseaseAutoimmune responses
The present invention relates to tetrahydrobenzo-isoquinoline sulfonamides derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use in treating disorders caused by IgE (such as allergic responses, non-allergic mast cell responses or certain autoimmune responses), and in particular disorders caused by the interaction of IgE with the FIERI receptor.
Owner:UCB BIOPHARMA SPRL

Method for preparing sodium storage hard carbon negative electrode material from heavy oil

The invention provides a method for preparing a sodium-storage hard carbon negative electrode material from heavy oil, which comprises the following steps: by taking the heavy oil as a raw material, doping 1wt%-5wt% of an acidic catalyst and an aldehyde crosslinking agent, and putting the mixture into a corrosion-resistant reaction kettle for shallow crosslinking polycondensation treatment; then carrying out air oxidation crosslinking to obtain an isotropic asphalt product with good fluidity and low quinoline insoluble content; and carrying out carbonization and acid-base etching treatment to prepare the sodium-storage hard carbon negative electrode material with excellent rate capability and long-period stability. According to the method, the utilization rate of small molecules in the ethylene tar is guaranteed through shallow cross-linking polycondensation by adding the acid catalyst and the aldehyde cross-linking agent, and the yield of the material is remarkably improved; and treating a cross-linked polycondensation product by using an oxidation cross-linking process to prepare the high-carbon-residue isotropic asphalt with different softening points and low quinoline insoluble content. On the basis of the process, a carbonization-acid-alkali etching process is utilized to treat isotropic asphalt, and the sodium storage hard carbon negative electrode material with high battery capacity, excellent rate capability and long-period stability is prepared.
Owner:CHINA UNIV OF PETROLEUM (EAST CHINA)

Oilfield water injection bactericide containing plant sterilization components and preparation method of oilfield water injection bactericide

The invention relates to the technical field of bactericides, and discloses an oilfield flooding bactericide containing plant bactericidal components and a preparation method thereof. The preparation method comprises the following steps: loading the plant-based traditional Chinese medicine extract and the isothiazolinone-based corrosion inhibitor on the silver-loaded cyclodextrin metal organic framework to prepare an antibacterial agent / silver-loaded cyclodextrin metal organic framework composite material, and mixing the antibacterial agent / silver-loaded cyclodextrin metal organic framework composite material with methyl methacrylate to prepare the antibacterial agent / silver-loaded cyclodextrin metal organic framework composite material. The bactericide obtained by carrying out copolymerization reaction on modified hydroxyquinoline, vinyl quaternary phosphonium salt and methacrylic acid through an in-situ polymerization method can effectively kill and inhibit the breeding of sulfate reducing bacteria and other bacteria in oilfield reinjection water, and has a certain corrosion inhibition effect.
Owner:ZHENGZHOU DERONG TECH CO LTD

Flow packed-bed photoreactor with gas-liquid separation for photocatalytic hydrogen production

The present disclosure relates to a photoreactor and method of use thereof. In an aspect, the photoreactor can be configured as a solar panel comprising a channel containing a heterogeneous photocatalyst. When water or another hydrogen-containing liquid is pumped through the photoreactor, it contacts the photocatalyst in the presence of UV or visible irradiation, simultaneously releasing hydrogen and separating the hydrogen via a gas-permeable membrane. In an aspect, the photoreactor can be used in a method for continuous production of high-purity H2 gas, the method comprising dehydrogenating tetrahydroquinoline (THQ) to form quinoline under visible light using a Rh / TiO2 heterogeneous photocatalyst. In another aspect, the catalyst includes Rh particles photodeposited on TiO2 microparticles. In a further aspect, the method can include regenerating THQ from quinoline using a water gas shift (WGS) reaction.
Owner:NORTH CAROLINA STATE UNIV

Anthracene azepine material as well as preparation method and application thereof

The invention relates to the technical field of OLED (Organic Light Emitting Diode) luminescent materials, in particular to an anthracene azepine material as well as a preparation method and application thereof, and the structure of the anthracene azepine material is as shown in the following formula: # imgabs0 #, r is any one of a deuterated terphenyl group, an isoquinolyl group, a piryl group, a 9, 9-diphenyl fluorenyl group, a dibenzothienyl group and a deuterated N-phenyl carbazolyl group. The parent structure of the anthracene-azepine material has anthracene, deuterated carbazole, azepine structures and the like, and intramolecular large steric hindrance space distorted structures, so that the spin-orbit coupling effect between different excited states is remarkably improved, the molecules are greatly limited during relaxation, and finally, the device realizes dark blue light emission, and has wide application prospects. The introduced aryl heterocyclic structure can greatly improve the stability of the material, and meanwhile, the deuterated structure can obviously prolong the service life of the device and obviously improve the luminous efficiency of the device.
Owner:YANTAI GEM CHEM CO LTD

Methods for the treatment and prevention of non-viral tick-borne diseases and symptoms thereof of

Methods and compositions for treating or preventing non-viral tick-borne diseases and symptoms thereof by administering a long half-life 8-aminoquinoline, such as tafenoquine, are disclosed. Kits including a means for testing for a non-viral tick-borne disease and / or symptoms thereof and a long half-life 8-aminoquinoline, such as tafenoquine, are disclosed.
Owner:60 DEGREES PHARMA +2

Isoquinolinone dihydropyridine-[1, 2-alpha] indole spiro compound as well as preparation method and application thereof

The invention discloses an isoquinolinone dihydropyridine-[1, 2-alpha] indole spiro compound as well as a preparation method and application thereof, and belongs to the technical field of synthesis of organic compounds. An N-indole connected o-alkynyl nitrone compound is used as a raw material, a two-step one-pot method is adopted, and the isoquinolinone dihydropyridine-[1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, the invention relates to a novel method for synthesizing a spiro [1, 2-alpha] indole. The method disclosed by the invention has the advantages of simplicity in operation, low catalyst loading capacity, wide reaction substrate range, single stereoselectivity, high yield and the like. The isoquinolinone dihydropyridine-[1, 2-alpha] indole spiro compound prepared by the invention has a certain inhibition effect on phytopathogen, and can be potentially applied to prevention and treatment of tomato gray mold, wheat scab and rhizoctonia solani.
Owner:NANJING FORESTRY UNIV

Composition for promoting mitochondrial autophagy activity comprising isoquinoline derivative compound as active ingredient and use thereof

The present invention relates to novel isoquinoline derivatives. The derivative has the effect of promoting mitochondrial autophagy activity, so that mitochondria with damaged structure and / or function is reduced. Specifically, the novel isoquinoline derivative according to the present invention does not induce mitochondrial dysfunction and has been determined as a safe compound that is non-toxic to cells, and thus it can be used to prevent, ameliorate and / or treat various diseases that may be caused by mitochondrial abnormality.
Owner:ALTMEDICAL CO LTD +1

Pharmaceutical intermediate and synthesis method, and isoquinoline derivative and synthesis method therefor

The present invention belongs to the technical field of drug synthesis, relating to the synthesis of drugs for the prevention or treatment of diseases such as Alzheimer's disease and Parkinson's disease. Specifically, it relates to pharmaceutical intermediates and synthesis methods and isoquinoline derivatives and synthesis methods therefor. The pharmaceutical intermediate has a chemical structure shown in Formula II, wherein X is a halogen, and R is an amino protecting group. The synthesis of the pharmaceutical intermediate is simple, operates under mild conditions, and results in a high yield. Additionally, the pharmaceutical intermediate can be used to prepare isoquinoline derivatives.
Owner:BANGENTAI (SHANDONG) BIOSCIENCES GRP SHARE CO LTD

Bacterial strain and method for producing pyrroloquinoline quinone

The invention discloses a bacterial strain and a method for producing pyrroloquinoline quinone. The strain is pseudomonas putida N1-1 which is preserved in the China General Microbiological Culture Collection Center on January 2, 2025, the preservation number is CGMCC NO.33266, and the preservation address is Institute of Microbiology, Chinese Academy of Sciences, No. 3, No.1 yard, West Beichen Road, Chaoyang District, Beijing. The strain is separated from myxomycete. The bacterial strain is inoculated into a fermentation culture medium, standing fermentation culture is carried out for 7 days at room temperature under the dark condition, a fermentation product is obtained and filtered, fermentation filtrate containing pyrroloquinoline quinine is obtained, and the yield of pyrroloquinoline quinine reaches 12.21 mg / L.
Owner:FUJIAN INST OF MICROBIOLOGY

Microorganism for degrading nitrogen-containing heterocyclic compound and application thereof in wastewater treatment

The invention discloses a microorganism for degrading a nitrogen-containing heterocyclic compound and application of the microorganism in wastewater treatment, and belongs to the technical field of wastewater treatment. The microorganism is Rhodococcus pyridinivorans Rho48 screened from activated sludge of a membrane bioreactor of a tin-free municipal sewage treatment plant, has broad spectrum, and can be used for degrading and mineralizing a plurality of nitrogen-containing heterocyclic compounds such as indole, quinoline, benzothiazole or pyridine. The bacillus subtilis can be used in combination with Rhodococcus ruber Rho4, the bacillus subtilis and the Rhodococcus ruber Rho4 can form a composite flora, and the degradation and mineralization effects on nitrogen-containing heterocyclic compounds, especially indole, can be further improved. The Rho48 can degrade and mineralize at least three nitrogen-containing heterocyclic compounds including quinoline, benzothiazole or pyridine regardless of whether the Rho48 is used alone or in combination with Rho4, so that the Rho48 has more selectivity when being used for treating nitrogen-containing heterocyclic compound wastewater, especially composite pollution wastewater containing multiple nitrogen-containing heterocyclic compounds at the same time.
Owner:NANJING UNIV

Iridium-containing metal heterocyclic phosphorescent doped material and organic electroluminescent device

The invention belongs to the technical field of organic electroluminescent materials, and provides an iridium-containing heterocyclic phosphorescent doping material and an organic electroluminescent device.The doping material has a compound general formula shown in the formula I. Quinoline and a naphthalene ring are connected through silane or germane, and a silicon or germanium six-membered heterocyclic structure is formed. And reacting with iridium metal and a diketone monomer to obtain the iridium metal heterocyclic phosphorescent organic light-emitting material. The heteroatom silicon or germanium in the material can adjust molecular orbital HOMO and LUMO energy levels, and the polarity effect of heteroatoms promotes electron migration, reduces interface potential barriers and electron injection barriers, reduces carrier injection loss and improves carrier mobility, so that driving voltage is reduced, and the external quantum efficiency of a device is improved. In addition, the silicon or germanium heterocyclic ring has better rigidity, so that the overall stability of the structure is enhanced, and the rigid structure can prolong the service life of the device.
Owner:JILIN OPTICAL & ELECTRONICS MATERIALS CO LTD